Screening in Myocardial Perfusion Patients
Completed
Conditions studied: Breast Cancer
In brief
To expand the understanding of the uptake and distribution of Tc-99m sestamibi in the breast in a normal female population undergoing myocardial perfusion imaging using Molecular Breast Imaging (MBI).
Key facts
- Study ID
- NCT00943241
- Run by
- Mayo Clinic
- People needed
- 322
- Starts
- 2008-07-01
- Expected to finish
- 2010-06-01
- Last updated by the study team
- 2013-02-13
Who can join
Age: 18 and older, up to 90. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- They have had a mammogram at Mayo Clinic Rochester within the last 12 months
- Undergoing myocardial perfusion imaging
You may not qualify if…
- They are unable to understand and sign the consent form
- They are physically unable to sit upright and still for 20 minutes
- They have undergone breast surgery or breast biopsy within the last 12 months.
- They have had trauma to the breast tissue or undergone radiation treatment to the breast within the last 12 months.
Where it is running
- Mayo Clinic — Rochester, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.